a

Topical Tapinarof Reduces Severity of Plaque Psoriasis

Response rate higher but more adverse events seen at week 12 in patients with plaque psoriasis receiving tapinarof versus vehicle control

By Physician’s Briefing Staff | December 09, 2021

HealthDay

Copyright © 2021 HealthDay. All rights reserved.

Related CME

Loading...
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved